EUVIMEDEUVIMED entdecken
Crossref

Nuclear eNOS Interacts With and S -Nitrosates ADAR1 to Modulate Type I Interferon Signaling and Endothelial Function

Xiaozhu Zhou, Carsten Kuenne iD, Stefan Günther iD, Ilka Wittig iD, Beyza Güven iD, Doha Boutguetait, Fredy Delgado Lagos iD, Nadja Sachs iD, Lars Maegdefessel iD, Oliver J Müller iD, Christian Münch iD, Stefan Offermanns iD und 2 weitere

Circulation · 23.12.2025 · 152 (25) · 1781-1799

DOI: 10.1161/circulationaha.125.074889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 23.12.2025. Verfasst von Xiaozhu Zhou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Vascular Signaling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany (X.Z., B.G., F.D.L., I.F., M.S.). Hauptthemen laut MEDLINE: Nitric Oxide Synthase Type III, Signal Transduction, Adenosine Deaminase, RNA-Binding Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Nitric oxide (NO), generated by the endothelial NO synthase (eNOS), regulates vascular tone and endothelial homeostasis to counteract vascular inflammation. Most eNOS is localized at the cell membrane or in the Golgi apparatus, but the enzyme is also present in the endothelial cell nucleus. Here, we assessed the relevance of nuclear eNOS and NO signaling for endothelial cell function. METHODS: eNOS loss-of-function approaches were combined with confocal microscopy and biochemical, histological, and multiomics analyses. The pathophysiological relevance of the findings was assessed in murine models of atherogenesis (hypercholesterolemia and partial carotid ligation) as well as in samples from patients with atherosclerosis. RESULTS: eNOS was present in the nucleus of unstimulated human and murine endothelial cells (in vitro and ex vivo) and stimulation with VEGF (vascular endothelial growth factor) enhanced its nuclear localization. Coimmunoprecipitation studies coupled with proteomics revealed the association of nuclear eNOS with 81 proteins involved in RNA binding and processing. Among the latter was ADAR1 (double-stranded RNA-specific adenosine deaminase), an enzyme involved in editing double-stranded RNA via the deamination of A to I. ADAR1 was S -nitrosated in human endothelial cells, and the knockdown of eNOS resulted in altered ADAR1-mediated A-to-I editing and an increase in double-stranded RNA. The latter phenomenon elicited aggregation of MAVS (mitochondrial antiviral signaling protein), activation of the type I IFN (interferon) signaling pathway and a marked downregulation of cell cycle–related genes. ADAR1 depletion elicited similar effects on the activation of type I IFN signaling. As a result, growth factor–stimulated cell proliferation was abrogated, and basal as well as stimulated cell death were increased in endothelial cells lacking eNOS. Endothelial dysfunction in mice as well as in subjects with atherosclerosis was accompanied by accumulation of double-stranded RNA and activation of type I IFN signaling. Preserving NO bioavailability in vivo (Tyr657Phe eNOS mice) prevented these effects. CONCLUSIONS: Our findings uncovered a novel mechanism linking nuclear eNOS-derived NO with the activity of ADAR1 to maintain vascular homeostasis. Reduced NO bioavailability results in previously unrecognized activation of a type I IFN response in the endothelium, which contributes to atherogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric Oxide Synthase Type IIISignal TransductionAdenosine DeaminaseRNA-Binding ProteinsInterferon Type ICell NucleusEndothelial CellsEndothelium, VascularHumansAnimalsMiceMaleMice, Inbred C57BLHuman Umbilical Vein Endothelial CellsMice, KnockoutNitric OxideAtherosclerosisCells, Cultured

Stichwörter der Autor:innen

ADAR1S-nitrosationdsRNAeNOStype I IFN signaling

Substanzen

Nitric Oxide Synthase Type IIIAdenosine DeaminaseRNA-Binding ProteinsNOS3 protein, humanInterferon Type IADAR protein, humanADAR1 protein, mouseNos3 protein, mouseNitric Oxide

Autor:innen und Institutionen

  • Institute for Vascular Signaling, Centre for Molecular Medicine, Goethe University, Frankfurt am Main, Germany (X.Z., B.G., F.D.L., I.F., M.S.).
  • Bioinformatics and Deep Sequencing Platform, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (C.K., S.G.).
  • Functional Proteomics, Institute of Cardiovascular Physiology, Goethe University, Frankfurt am Main, Germany (I.W.).
  • Institute of Molecular Systems Medicine, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany (D.B., C.M.).
  • Department for Vascular and Endovascular Surgery, Klinikum rechts der Isar (N.S.) , Munich, Germany.
  • Technical University Munich, Munich, Germany (N.S.).

ORCID-Profile: Carsten Kuenne, Stefan Günther, Ilka Wittig, Beyza Güven, Fredy Delgado Lagos, Nadja Sachs, Lars Maegdefessel, Oliver J Müller, Christian Münch, Stefan Offermanns, Ingrid Fleming, Mauro Siragusa

Zitieren

APA

Zhou, X., Kuenne, C., Günther, S., Wittig, I., Güven, B., Boutguetait, D., Delgado Lagos, F., Sachs, N., Maegdefessel, L., Müller, O. J., Münch, C., Offermanns, S., Fleming, I., & Siragusa, M. (2025). Nuclear eNOS Interacts With and S -Nitrosates ADAR1 to Modulate Type I Interferon Signaling and Endothelial Function. Circulation, 152(25), 1781-1799. https://doi.org/10.1161/circulationaha.125.074889

Vancouver

Zhou X, Kuenne C, Günther S, Wittig I, Güven B, Boutguetait D, et al. Nuclear eNOS Interacts With and S -Nitrosates ADAR1 to Modulate Type I Interferon Signaling and Endothelial Function. Circulation. 2025;152(25):1781-1799. doi:10.1161/circulationaha.125.074889

BibTeX
@article{Zhou2025,
  author = {Zhou, Xiaozhu and Kuenne, Carsten and Günther, Stefan and Wittig, Ilka and Güven, Beyza and Boutguetait, Doha and Delgado Lagos, Fredy and Sachs, Nadja and Maegdefessel, Lars and Müller, Oliver J and Münch, Christian and Offermanns, Stefan and Fleming, Ingrid and Siragusa, Mauro},
  title = {Nuclear eNOS Interacts With and S -Nitrosates ADAR1 to Modulate Type I Interferon Signaling and Endothelial Function},
  journal = {Circulation},
  year = {2025},
  volume = {152},
  number = {25},
  pages = {1781--1799},
  doi = {10.1161/circulationaha.125.074889}
}
Kostenlos starten →